Back to Search
Start Over
Durable Remissions with Single Agent As2O3in the Treatment of Newly Diagnosed Cases of Acute Promyelocytic Leukemia: Risk Stratification within This Group and Potential Impact on Future Algorithms.
- Source :
- Blood; November 2005, Vol. 106 Issue: 11 p892-892, 1p
- Publication Year :
- 2005
-
Abstract
- There is limited long term follow up data with the use of single agent As2O3in the treatment of newly diagnosed cases of acute promyelocytic leukemia (APL).
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 106
- Issue :
- 11
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56858775
- Full Text :
- https://doi.org/10.1182/blood.V106.11.892.892